Table 1.
Demographic features and follicular fluid aggrecan and ADAMTS-1 levels in the study groups
| PCOS group (n = 21) Mean ± SD |
Control group (n = 22) Mean ± SD |
p value | |
|---|---|---|---|
| Age | 29.23 ± 3.67 | 29.09 ± 3.61 | 0.88 |
| Partner’s age | 31.95 ± 4.64 | 33.54 ± 3.85 | 0.210 |
| BMI | 27.87 ± 5.90 | 25.18 ± 5.40 | 0.120 |
| MII percentage (%) | 62 ± 17 | 70 ± 25 | 0.24 |
| Oocyte number | 16.19 ± 7.23 | 8.18 ± 5.08 | <0.001 |
| MII number | 9.57 ± 4.53 | 5.59 ± 3.78 | 0.003 |
| MI number | 3.09 ± 1.89 | 1.36 ± 2.32 | 0.011 |
| FSH (mlU/ml) | 7.30 ± 1.82 | 7.49 ± 1.97 | 0.744 |
| LH (mlU/ml) | 6.06 ± 3.15 | 4.91 ± 2.64 | 0.201 |
| E2 (pg/ml) | 79.04 ± 11.74 | 67.00 ± 39.39 | 0.003 |
| PG (ng/ml) | 0.79 ± 0.38 | 0.68 ± 0.29 | 0.300 |
| Aggrecan (ng/ml) | 8.05 ± 4.78 | 3.63 ± 2.18 | <0.001 |
| ADAMTS-1 (ng/ml) | 33.84 ± 17.70 | 23.58 ± 5.67 | 0.013 |
BMI body mass index, MII metaphase II, MI metaphase I, FSH follicle-stimulating hormone, LH luteinizing hormone, PG progesterone, ADAMTS-1 a disintegrin-like and metalloproteinase with thrombospondin type motifs.
Italic emphasizes reflected inside the table represent statistical significance (p<0.005)